NASDAQ:VRAY - Viewray Stock Price, Price Target & More

$7.72 -0.01 (-0.13 %)
(As of 04/23/2018 04:00 PM ET)
Previous Close$7.73
Today's Range$7.47 - $7.78
52-Week Range$4.40 - $10.64
Volume500,804 shs
Average Volume657,043 shs
Market Capitalization$554.58 million
P/E Ratio-7.24
Dividend YieldN/A
Beta0.64

About Viewray (NASDAQ:VRAY)

Viewray logoViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company's software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.

Receive VRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for VRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:VRAY
CUSIPN/A
Phone440-703-3210

Debt

Debt-to-Equity Ratio22.47%
Current Ratio2.18%
Quick Ratio1.84%

Price-To-Earnings

Trailing P/E Ratio-7.24
Forward P/E Ratio-10.87
P/E GrowthN/A

Sales & Book Value

Annual Sales$34.04 million
Price / Sales16.27
Cash FlowN/A
Price / CashN/A
Book Value$0.03 per share
Price / Book257.33

Profitability

EPS (Most Recent Fiscal Year)($1.04)
Net Income$-72,170,000.00
Net Margins-212.02%
Return on EquityN/A
Return on Assets-60.04%

Miscellaneous

Employees139
Outstanding Shares71,740,000

How to Become a New Pot Stock Millionaire

Viewray (NASDAQ:VRAY) Frequently Asked Questions

What is Viewray's stock symbol?

Viewray trades on the NASDAQ under the ticker symbol "VRAY."

How were Viewray's earnings last quarter?

Viewray Inc (NASDAQ:VRAY) announced its earnings results on Monday, March, 12th. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.25) by $0.13. The company earned $19.90 million during the quarter, compared to analyst estimates of $21.23 million. The company's revenue was up 23.6% compared to the same quarter last year. View Viewray's Earnings History.

What price target have analysts set for VRAY?

6 equities research analysts have issued 12 month target prices for Viewray's shares. Their forecasts range from $10.00 to $13.50. On average, they expect Viewray's stock price to reach $11.5833 in the next year. View Analyst Ratings for Viewray.

What are Wall Street analysts saying about Viewray stock?

Here are some recent quotes from research analysts about Viewray stock:
  • 1. Mizuho analysts commented, "We were at the Advanced Applications of MR-Guided Radiotherapy Symposium in Amsterdam on March 16th, 2018. The event was very well attended with approximately 200 people; most were potential customers who showed strong interest in ViewRay’s MRIdian. We highlight our key takeaways from the conference and additional insights into the MRI Linac below. Overall, we maintain our view that ViewRay has leadership in real time imaging guided LINAC today." (4/19/2018)
  • 2. Northland Securities analysts commented, "We are maintaining our FY17 & FY18 numbers, and our PT & ratings remain the same. Key Points Perhaps the most interesting takeaway from the call was the announcement of a multi-institutional trial on unresectable pancreatic cancer using MRIdian. It is our understanding that this trial will include both MRIdian Cobalt & LINAC (as they become available); will include a hard endpoint like survival, and possibly" intraop dose titration and impact on outcomes. As a reminder, most patients with pancreatic cancer will die within 1 – 2 years, with median survival @ 1-year. Hence, it is certainly possible that ViewRay could provide survival endpoints for such a trial in late 2018 / early 2019. This obviously is predicated on the trial design, sample size, inclusion criteria, and whether this will be randomized or not. The ideal design would obviously be to include a comparative arm with another RT machine (like the TruBeam) & compare to MRIdian. Finally, how outcomes will be influenced with the use of Cobalt vs. LINAC will also be interesting to note, although it might be hard to draw any statistical conclusions given small sample size." (5/16/2017)
  • 3. Aegis analysts commented, "We are assuming coverage of VRAY with a Buy rating and $11 PT. We believe the MRI-guided LINAC is a game-changer in radiation oncology, with real-time imaging improving dosimetry and reducing the toxicity to patients. The combination improves functionality and expands the use of stereotactic body radiation therapy (SBRT), and physicians believe the system can expand the total treatable tumors by at least 20%." (5/16/2017)

Who are some of Viewray's key competitors?

When did Viewray IPO?

(VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel served as the underwriters for the IPO and BTIG and Brean Capital were co-managers.

Has Viewray been receiving favorable news coverage?

News articles about VRAY stock have been trending somewhat positive this week, according to Accern. Accern identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Viewray earned a coverage optimism score of 0.14 on Accern's scale. They also assigned press coverage about the company an impact score of 46.13 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Viewray?

Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Viewray's stock price today?

One share of VRAY stock can currently be purchased for approximately $7.68.

How big of a company is Viewray?

Viewray has a market capitalization of $554.58 million and generates $34.04 million in revenue each year. The company earns $-72,170,000.00 in net income (profit) each year or ($1.04) on an earnings per share basis. Viewray employs 139 workers across the globe.

How can I contact Viewray?

Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected]


MarketBeat Community Rating for Viewray (VRAY)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  115 (Vote Outperform)
Underperform Votes:  74 (Vote Underperform)
Total Votes:  189
MarketBeat's community ratings are surveys of what our community members think about Viewray and other stocks. Vote "Outperform" if you believe VRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Viewray (NASDAQ:VRAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Viewray in the last 12 months. Their average twelve-month price target is $11.5833, suggesting that the stock has a possible upside of 50.04%. The high price target for VRAY is $13.50 and the low price target for VRAY is $10.00. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.5833$11.5833$11.20$10.00
Price Target Upside: 50.04% upside41.61% upside24.58% upside55.28% upside

Viewray (NASDAQ:VRAY) Consensus Price Target History

Price Target History for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ:VRAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/19/2018MizuhoReiterated RatingBuy$12.00HighView Rating Details
2/8/2018B. RileyInitiated CoverageBuy -> Buy$13.50LowView Rating Details
1/8/2018Cantor FitzgeraldSet Price TargetBuy$13.00MediumView Rating Details
11/17/2017Northland SecuritiesReiterated RatingBuy$10.00N/AView Rating Details
7/22/2017AegisReiterated RatingBuy$11.00HighView Rating Details
5/17/2017BTIG ResearchReiterated RatingBuy$10.00MediumView Rating Details
(Data available from 4/23/2016 forward)

Earnings

Viewray (NASDAQ:VRAY) Earnings History and Estimates Chart

Earnings by Quarter for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ:VRAY) Earnings Estimates

2018 EPS Consensus Estimate: ($0.79)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.24)($0.21)($0.23)
Q2 20182($0.21)($0.21)($0.21)
Q3 20182($0.19)($0.18)($0.19)
Q4 20182($0.17)($0.17)($0.17)

Viewray (NASDAQ VRAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/12/2018Q4 2017($0.25)($0.38)$21.23 million$19.90 millionViewListenView Earnings Details
11/13/2017Q3 2017($0.12)($0.19)$18.63 million$12.20 millionViewN/AView Earnings Details
8/7/2017Q2 2017($0.24)($0.26)$0.68 million$0.70 millionViewListenView Earnings Details
5/15/2017Q1 2017($0.22)($0.24)$0.52 million$1.23 millionViewN/AView Earnings Details
3/16/2017Q4 2016($0.34)($0.25)$13.65 million$16.13 millionViewN/AView Earnings Details
11/14/2016Q316($0.27)($0.35)$0.39 million$0.36 millionViewN/AView Earnings Details
8/15/2016Q216($0.29)($0.32)$5.53 million$0.30 millionViewListenView Earnings Details
5/13/2016Q116($0.30)($0.35)$5.50 million$5.50 millionViewN/AView Earnings Details
3/28/2016Q4 2015($0.37)$4.61 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.35)$5.32 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Viewray (NASDAQ:VRAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Viewray (NASDAQ VRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 62.81%
Institutional Ownership Percentage: 76.31%
Insider Trading History for Viewray (NASDAQ:VRAY)
Insider Trading History for Viewray (NASDAQ:VRAY)

Viewray (NASDAQ VRAY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/14/2018James F DempseyInsiderSell75,243$7.57$569,589.51View SEC Filing  
4/25/2017Fmr LlcInsiderSell106,781$6.76$721,839.56View SEC Filing  
4/24/2017Fmr LlcInsiderSell101,139$6.71$678,642.69View SEC Filing  
4/20/2017Fmr LlcInsiderSell101,236$6.90$698,528.40View SEC Filing  
4/18/2017Fmr LlcInsiderSell107,217$7.24$776,251.08View SEC Filing  
4/13/2017Fmr LlcInsiderSell115,860$7.44$861,998.40View SEC Filing  
4/12/2017Fmr LlcInsiderSell179,494$7.40$1,328,255.60View SEC Filing  
4/10/2017Fmr LlcInsiderSell178,556$7.77$1,387,380.12View SEC Filing  
4/7/2017Fmr LlcInsiderSell52,050$7.89$410,674.50View SEC Filing  
4/5/2017Fmr LlcInsiderSell196,397$7.90$1,551,536.30View SEC Filing  
4/3/2017Fmr LlcInsiderSell217,883$8.29$1,806,250.07View SEC Filing  
3/30/2017Fmr LlcInsiderSell28,661$8.46$242,472.06View SEC Filing  
1/18/2017Ajay BansalCFOBuy62,597$3.17$198,432.4970,104View SEC Filing  
1/18/2017Henry A. MckinnellDirectorBuy312,989$3.17$992,175.13View SEC Filing  
9/9/2016Aditya PuriDirectorBuy1,472,803$2.95$4,344,768.8518,964View SEC Filing  
8/22/2016David P BonitaDirectorBuy1,138,074$2.95$3,357,318.30View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Viewray (NASDAQ VRAY) News Headlines

Source:
DateHeadline
Zacks: Brokerages Anticipate Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per ShareZacks: Brokerages Anticipate Viewray Inc (VRAY) Will Post Earnings of -$0.22 Per Share
www.americanbankingnews.com - April 23 at 5:12 AM
Reviewing Viewray (VRAY) and Zynex (ZYXI)Reviewing Viewray (VRAY) and Zynex (ZYXI)
www.americanbankingnews.com - April 22 at 7:26 AM
VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR ...VU University Medical Center in Amsterdam Delivers First Ever Linear Accelerator-Based On-Table Adaptive MR ...
www.prnewswire.com - April 19 at 5:57 PM
Viewray Target of Unusually Large Options Trading (VRAY)Viewray Target of Unusually Large Options Trading (VRAY)
www.americanbankingnews.com - April 19 at 8:00 AM
Viewrays (VRAY) Buy Rating Reaffirmed at MizuhoViewray's (VRAY) Buy Rating Reaffirmed at Mizuho
www.americanbankingnews.com - April 19 at 6:50 AM
ViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided RadiotherapyViewRay Unveils New Soft Tissue Visualization Technologies to Further Advance MR Image-Guided Radiotherapy
finance.yahoo.com - April 18 at 5:38 PM
Viewray (VRAY) Upgraded to "Sell" by BidaskClubViewray (VRAY) Upgraded to "Sell" by BidaskClub
www.americanbankingnews.com - April 13 at 9:39 AM
Trimedyne (TMED) versus Viewray (VRAY) Financial ContrastTrimedyne (TMED) versus Viewray (VRAY) Financial Contrast
www.americanbankingnews.com - April 10 at 9:14 PM
Viewray Inc (VRAY) Expected to Post Quarterly Sales of $15.50 MillionViewray Inc (VRAY) Expected to Post Quarterly Sales of $15.50 Million
www.americanbankingnews.com - April 8 at 4:31 AM
-$0.22 Earnings Per Share Expected for Viewray Inc (VRAY) This Quarter-$0.22 Earnings Per Share Expected for Viewray Inc (VRAY) This Quarter
www.americanbankingnews.com - April 6 at 9:01 AM
Mizuho Reiterates "Buy" Rating for Viewray (VRAY)Mizuho Reiterates "Buy" Rating for Viewray (VRAY)
www.americanbankingnews.com - April 5 at 12:39 PM
University Clinic Heidelberg Completes Installation and Commissioning of ViewRays MRIdian MR Image-Guided ...University Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided ...
www.prnewswire.com - April 4 at 4:32 PM
University Clinic Heidelberg Completes Installation and Commissioning of ViewRays MRIdian MR Image-Guided Radiotherapy LinacUniversity Clinic Heidelberg Completes Installation and Commissioning of ViewRay's MRIdian MR Image-Guided Radiotherapy Linac
finance.yahoo.com - April 4 at 4:32 PM
Technical Perspectives on Medical Equipment Stocks -- Smith & Nephew, Stryker, ViewRay, and Zimmer BiometTechnical Perspectives on Medical Equipment Stocks -- Smith & Nephew, Stryker, ViewRay, and Zimmer Biomet
www.prnewswire.com - April 2 at 8:54 AM
Viewray Inc (VRAY) Given Average Recommendation of "Buy" by BrokeragesViewray Inc (VRAY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - April 1 at 8:03 AM
Viewray (VRAY) PT Set at $13.00 by Cantor FitzgeraldViewray (VRAY) PT Set at $13.00 by Cantor Fitzgerald
www.americanbankingnews.com - March 30 at 12:35 PM
Viewrays (VRAY) "Buy" Rating Reiterated at MizuhoViewray's (VRAY) "Buy" Rating Reiterated at Mizuho
www.americanbankingnews.com - March 29 at 10:16 PM
BidaskClub Lowers Viewray (VRAY) to HoldBidaskClub Lowers Viewray (VRAY) to Hold
www.americanbankingnews.com - March 29 at 3:00 PM
Viewray (VRAY) Lowered to Strong Sell at BidaskClubViewray (VRAY) Lowered to Strong Sell at BidaskClub
www.americanbankingnews.com - March 28 at 8:05 AM
RAD Technology Medical Systems Purchases Two ViewRay MRIdian Linac SystemsRAD Technology Medical Systems Purchases Two ViewRay MRIdian Linac Systems
www.prnewswire.com - March 27 at 5:30 PM
ViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer TreatmentViewRay Surpasses 50th Order for MRIdian® System for Precision Cancer Treatment
finance.yahoo.com - March 27 at 5:30 PM
Brokers Issue Forecasts for Viewray Incs FY2018 Earnings (VRAY)Brokers Issue Forecasts for Viewray Inc's FY2018 Earnings (VRAY)
www.americanbankingnews.com - March 22 at 10:40 AM
$13.80 Million in Sales Expected for Viewray Inc (VRAY) This Quarter$13.80 Million in Sales Expected for Viewray Inc (VRAY) This Quarter
www.americanbankingnews.com - March 22 at 5:54 AM
VRAY: 2018 Could Be Pivotal For ViewRayVRAY: 2018 Could Be Pivotal For ViewRay
finance.yahoo.com - March 21 at 5:55 PM
Zacks Investment Research Weighs in on Viewray Incs Q1 2018 Earnings (VRAY)Zacks Investment Research Weighs in on Viewray Inc's Q1 2018 Earnings (VRAY)
www.americanbankingnews.com - March 21 at 6:46 AM
-$0.23 EPS Expected for Viewray Inc (VRAY) This Quarter-$0.23 EPS Expected for Viewray Inc (VRAY) This Quarter
www.americanbankingnews.com - March 20 at 9:00 AM
Stock Traders Purchase High Volume of Viewray Call Options (VRAY)Stock Traders Purchase High Volume of Viewray Call Options (VRAY)
www.americanbankingnews.com - March 20 at 6:42 AM
Stock Traders Buy High Volume of Put Options on Viewray (VRAY)Stock Traders Buy High Volume of Put Options on Viewray (VRAY)
www.americanbankingnews.com - March 20 at 6:40 AM
Viewray (VRAY) Downgraded by BidaskClub to "Sell"Viewray (VRAY) Downgraded by BidaskClub to "Sell"
www.americanbankingnews.com - March 18 at 4:24 PM
Reviewing Viewray (VRAY) & Accuray (ARAY)Reviewing Viewray (VRAY) & Accuray (ARAY)
www.americanbankingnews.com - March 17 at 1:02 AM
Reviewing Boston Scientific (BSX) and Viewray (VRAY)Reviewing Boston Scientific (BSX) and Viewray (VRAY)
www.americanbankingnews.com - March 16 at 9:06 PM
Viewray Inc (VRAY) Insider Sells $569,589.51 in StockViewray Inc (VRAY) Insider Sells $569,589.51 in Stock
www.americanbankingnews.com - March 16 at 7:52 PM
Viewray Inc (VRAY) to Post FY2018 Earnings of ($0.64) Per Share, Cantor Fitzgerald ForecastsViewray Inc (VRAY) to Post FY2018 Earnings of ($0.64) Per Share, Cantor Fitzgerald Forecasts
www.americanbankingnews.com - March 16 at 10:02 AM
Nearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided RadiotherapyNearly 200 Oncology Experts Gather to Discuss Advanced Applications of MR Image-Guided Radiotherapy
finance.yahoo.com - March 16 at 8:42 AM
ViewRays MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin)ViewRay's MRIdian MR Image-Guided Radiotherapy Linac Receives Japanese Regulatory Approval (Shonin)
finance.yahoo.com - March 15 at 9:19 AM
Q1 2018 EPS Estimates for Viewray Inc Cut by B. Riley (VRAY)Q1 2018 EPS Estimates for Viewray Inc Cut by B. Riley (VRAY)
www.americanbankingnews.com - March 15 at 6:28 AM
ViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital ZurichViewRay Finalizes Order for MR Image-Guided Radiation Therapy System at University Hospital Zurich
finance.yahoo.com - March 14 at 5:43 PM
ViewRay Inc. (VRAY) PT Maintained at $12 at Mizuho Securities on 4Q Report; Not Concerned... 2018 Guidance Likely ... - StreetInsider.comViewRay Inc. (VRAY) PT Maintained at $12 at Mizuho Securities on 4Q Report; 'Not Concerned... 2018 Guidance Likely ... - StreetInsider.com
www.streetinsider.com - March 13 at 9:28 AM
ViewRay Reports Fourth Quarter and Full Year 2017 Financial ResultsViewRay Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 12 at 5:44 PM
What Is ViewRay Inc’s (NASDAQ:VRAY) Share Price Doing?What Is ViewRay Inc’s (NASDAQ:VRAY) Share Price Doing?
finance.yahoo.com - March 12 at 5:44 PM
Viewray (VRAY) Posts Quarterly  Earnings Results, Misses Estimates By $0.17 EPSViewray (VRAY) Posts Quarterly Earnings Results, Misses Estimates By $0.17 EPS
www.americanbankingnews.com - March 12 at 9:20 AM
B. Riley Equities Analysts Raise Earnings Estimates for Viewray Inc (VRAY)B. Riley Equities Analysts Raise Earnings Estimates for Viewray Inc (VRAY)
www.americanbankingnews.com - March 12 at 2:50 AM
Pre-Market Earnings Report for March 12, 2018 : ACRS, VRAY, TNP, NERV, EGLT - NasdaqPre-Market Earnings Report for March 12, 2018 : ACRS, VRAY, TNP, NERV, EGLT - Nasdaq
www.nasdaq.com - March 9 at 5:54 PM
Viewray Inc (VRAY) Receives Average Rating of "Buy" from AnalystsViewray Inc (VRAY) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - March 7 at 12:27 PM
ViewRay Announces Conference Call and Webcast of Fourth ... - PR Newswire (press release)ViewRay Announces Conference Call and Webcast of Fourth ... - PR Newswire (press release)
www.prnewswire.com - March 7 at 8:31 AM
ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2017 Financial Results to be Held on March 12, 2018ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2017 Financial Results to be Held on March 12, 2018
finance.yahoo.com - March 6 at 5:32 PM
947,306 Shares in Viewray Inc (VRAY) Acquired by Sectoral Asset Management Inc947,306 Shares in Viewray Inc (VRAY) Acquired by Sectoral Asset Management Inc
www.americanbankingnews.com - March 5 at 3:35 PM
 Analysts Anticipate Viewray Inc (VRAY) Will Announce Quarterly Sales of $20.09 Million Analysts Anticipate Viewray Inc (VRAY) Will Announce Quarterly Sales of $20.09 Million
www.americanbankingnews.com - March 5 at 9:58 AM
Next Century Growth Investors LLC Has $5.49 Million Position in Viewray Inc (VRAY)Next Century Growth Investors LLC Has $5.49 Million Position in Viewray Inc (VRAY)
www.americanbankingnews.com - March 3 at 3:55 PM
Viewray Target of Unusually High Options Trading (VRAY)Viewray Target of Unusually High Options Trading (VRAY)
www.americanbankingnews.com - March 1 at 8:36 AM

SEC Filings

Viewray (NASDAQ:VRAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Viewray (NASDAQ VRAY) Stock Chart for Monday, April, 23, 2018

Loading chart…

This page was last updated on 4/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.